News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,287 Results
Type
Article (69559)
Company Profile (245)
Press Release (691468)
Multimedia
Podcasts (141)
Webinars (24)
Section
Business (199752)
Career Advice (3169)
Deals (36222)
Drug Delivery (136)
Drug Development (87850)
Employer Resources (172)
FDA (17176)
Job Trends (15527)
News (350082)
Policy (34208)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2925)
Academic (2)
Accelerated approval (37)
Adcomms (36)
Allergies (153)
Alliances (49803)
ALS (183)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (357)
Approvals (17379)
Artificial intelligence (587)
Autoimmune disease (182)
Automation (41)
Bankruptcy (330)
Best Places to Work (12042)
BIOSECURE Act (18)
Biosimilars (205)
Biotechnology (171)
Bladder cancer (168)
Brain cancer (66)
Breast cancer (687)
Cancer (5199)
Cardiovascular disease (456)
Career advice (2711)
Career pathing (40)
CAR-T (313)
CDC (59)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (38)
Clinical research (74600)
Collaboration (1856)
Company closure (5)
Compensation (1051)
Complete response letters (76)
COVID-19 (2871)
CRISPR (103)
C-suite (931)
Cystic fibrosis (155)
Data (6461)
Decentralized trials (2)
Denatured (46)
Depression (158)
Diabetes (529)
Diagnostics (7089)
Digital health (50)
Diversity (13)
Diversity, equity & inclusion (43)
Drug discovery (282)
Drug pricing (215)
Drug shortages (31)
Duchenne muscular dystrophy (246)
Earnings (80155)
Editorial (65)
Employer branding (20)
Employer resources (152)
Events (121819)
Executive appointments (1050)
FDA (20438)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1571)
Gene editing (221)
Generative AI (54)
Gene therapy (662)
GLP-1 (1090)
Government (5217)
Grass and pollen (8)
Guidances (387)
Healthcare (20195)
HIV (67)
Huntington's disease (48)
IgA nephropathy (89)
Immunology and inflammation (297)
Immuno-oncology (70)
Indications (118)
Infectious disease (3171)
Inflammatory bowel disease (215)
Inflation Reduction Act (15)
Influenza (123)
Intellectual property (261)
Interviews (612)
IPO (16973)
IRA (57)
Job creations (3865)
Job search strategy (2221)
JPM (67)
Kidney cancer (18)
Labor market (80)
Layoffs (630)
Leadership (40)
Legal (7765)
Liver cancer (99)
Longevity (16)
Lung cancer (703)
Lymphoma (392)
Machine learning (41)
Management (60)
Manufacturing (825)
MASH (177)
Medical device (14228)
Medtech (14285)
Mergers & acquisitions (20394)
Metabolic disorders (1391)
Multiple sclerosis (170)
NASH (22)
Neurodegenerative disease (355)
Neuropsychiatric disorders (104)
Neuroscience (3147)
Neurotech (1)
NextGen: Class of 2026 (7048)
Non-profit (4866)
Now hiring (28)
Obesity (666)
Opinion (330)
Ovarian cancer (172)
Pain (217)
Pancreatic cancer (243)
Parkinson's disease (307)
Partnered (34)
Patents (527)
Patient recruitment (523)
Peanut (62)
People (62775)
Pharmaceutical (50)
Pharmacy benefit managers (32)
Phase 1 (23112)
Phase 2 (32584)
Phase 3 (24384)
Pipeline (5555)
Policy (323)
Postmarket research (3143)
Preclinical (10100)
Press Release (68)
Prostate cancer (257)
Psychedelics (59)
Radiopharmaceuticals (307)
Rare diseases (950)
Real estate (6496)
Recruiting (72)
Regulatory (26026)
Reports (44)
Research institute (2647)
Resumes & cover letters (485)
Rett syndrome (28)
RNA editing (18)
RSV (88)
Schizophrenia (160)
Series A (263)
Series B (201)
Service/supplier (10)
Sickle cell disease (106)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (46)
Startups (3790)
State (2)
Stomach cancer (21)
Supply chain (104)
Tariffs (86)
The Weekly (93)
Vaccines (1125)
Venture capital (92)
Weight loss (445)
Women's health (92)
Worklife (21)
Date
Last 7 days (596)
Last 30 days (2368)
Last 365 days (31221)
2026 (4183)
2025 (31678)
2024 (36330)
2023 (41096)
2022 (52252)
2021 (56956)
2020 (55732)
2019 (49136)
2018 (37296)
2017 (34360)
2016 (34100)
2015 (39873)
2014 (33284)
2013 (29175)
2012 (30825)
2011 (30900)
2010 (29912)
Location
Africa (1007)
Alabama (89)
Alaska (7)
Arizona (293)
Arkansas (14)
Asia (44677)
Australia (7839)
California (11470)
Canada (3328)
China (1186)
Colorado (487)
Connecticut (502)
Delaware (349)
Europe (104312)
Florida (1701)
Georgia (369)
Hawaii (3)
Idaho (63)
Illinois (932)
India (72)
Indiana (546)
Iowa (20)
Japan (444)
Kansas (127)
Kentucky (44)
Louisiana (28)
Maine (83)
Maryland (1410)
Massachusetts (8363)
Michigan (348)
Minnesota (631)
Mississippi (6)
Missouri (139)
Montana (36)
Nebraska (26)
Nevada (125)
New Hampshire (85)
New Jersey (3122)
New Mexico (32)
New York (3086)
North Carolina (1543)
North Dakota (10)
Northern California (5568)
Ohio (350)
Oklahoma (23)
Oregon (45)
Pennsylvania (2272)
Puerto Rico (25)
Rhode Island (43)
South America (1375)
South Carolina (67)
South Dakota (1)
Southern California (4499)
Tennessee (178)
Texas (1798)
United States (41234)
Utah (345)
Vermont (1)
Virginia (273)
Washington D.C. (79)
Washington State (949)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
761,287 Results for "cancer treatment centers of a...".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
In this episode of Denatured, Jennifer C. Smith-Parker speaks with Dr. Rob Monroe and Jennifer Fakish at Danaher Corporation. They discuss how antibody drug conjugates (ADCs) are transforming cancer care. With AI-powered pathology, doctors can now measure HER2 more precisely to match patients with the best treatments.
February 12, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
February 5, 2026
·
3 min read
Press Releases
NYU Langone Health’s Perlmutter Cancer Center Announces Upcoming Launch of Molecular Profiling Protocols to Monitor Cancer Treatments
January 13, 2026
·
3 min read
Press Releases
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
January 20, 2026
·
11 min read
Press Releases
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
February 17, 2026
·
11 min read
Press Releases
First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials
January 21, 2026
·
4 min read
Press Releases
Sensing Local Fibers in Pancreatic Tumors, Cancer Cells ‘Choose’ to Either Grow or Tolerate Treatment
February 17, 2026
·
5 min read
Press Releases
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
February 12, 2026
·
19 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
·
5 min read
Press Releases
Alessa Therapeutics Announces FDA Fast Track Designation for Enolen, A First-Of-Its-Kind Treatment for Localized Prostate Cancer
January 9, 2026
·
3 min read
1 of 76,129
Next
